Organogenesis Holdings Inc.
ORGO
$5.02
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 74.90% | 44.89% | -797.29% | 1,450.88% | 289.48% |
| Total Depreciation and Amortization | 10.60% | 8.93% | 7.88% | 5.63% | 16.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.28% | -59.97% | 76.94% | -41.86% | -14.24% |
| Change in Net Operating Assets | -115.77% | -404.23% | -0.05% | -155.62% | -558.09% |
| Cash from Operations | -64.59% | -793.82% | -96.17% | 3.04% | -48.04% |
| Capital Expenditure | 13.00% | -93.51% | -63.19% | -1.11% | 57.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 13.00% | -93.51% | -63.19% | -1.11% | 57.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 82.40% | 82.79% | 82.91% | -3,421.99% | -17.05% |
| Issuance of Common Stock | 2,500.00% | -- | -86.11% | 106,200.00% | -- |
| Repurchase of Common Stock | -- | 100.00% | -60.36% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -508.65% | 83.32% | 21.17% | 1,993.58% | -16.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -310.45% | -3,353.67% | -70.87% | 647.78% | -52.25% |